Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

How NY Atty Helped Win 12-Year Fight Over Hospital Pricing No Photo Available

Daniel Connolly

When Matthew Cantor got involved in a sweeping antitrust case against California-based healthcare network Sutter Health, his youngest ... (more story)

NC Biz Court Bulletin: Trade Secrets Row, A Patient Data Deal No Photo Available

Hayley Fowler

The North Carolina Business Court closed out the year by tossing a trade secrets fight brought by a corrugated packing manufacturer ag... (more story)

The Future of The 340B Rebate Pilot No Photo Available

Yeji Jesse Lee

A federal judge halted a new 340B pilot program, handing a win for safety net healthcare providers. Healthcare attorneys say it's too ... (more story)